Shares of Covance traded down 0.43% during mid-day trading on Friday, hitting $46.36. Covance has a one year low of $42.02 and a one year high of $63.86. The company has a market cap of $2.677 billion and a P/E ratio of 20.98.
Covance last issued its quarterly earnings data on Wednesday, May 2nd. The company reported $0.68 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.60 by $0.08. The company’s quarterly revenue was up 8.8% on a year-over-year basis. On average, analysts predict that Covance will post $0.69 earnings per share next quarter.
Covance Inc. (Covance) is a drug development services company providing a range of early-stage and late-stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.